Shows
BELS Brief Chats podcastBELS Brief Chat #14 with Nigel Gaymond and Dr Gillian Cannon
Dr Gillian Cannon currently serves on multiple boards and in an executive role at Roivant as Head of Commercial Innovation. Her 30-year career has included leadership roles in major pharma including Merck & Co, UCB and Otsuka Pharma. She hails from Newcastle, received her BSc from Edinburgh University and earned her PhD in Health Administration at Temple University. While Gillian resides in Princeton, New Jersey, she generously shares her expertise, experience, perspectives, and time with organizations and individuals in the UK, e.g., serving on the boards of Edinburgh Innovation and Our Future Health*, the UK’s largest ever health res...2023-08-3052 min
BELS Brief Chats podcastBELS Brief Chats #13 – Professor Will Harvey
Will Harvey, MPhil, BA, PhD—Professor of Leadership at the University of Bristol School of Management when we recorded this episode of BELS Brief Chats—conducts research, teaches and consults in the areas of reputation, leadership, talent management and migration. He has worked with pharmaceutical, healthcare, energy, mining, management consulting, executive search, local and national government, supranational, aviation and food organisations. He has studied, taught and worked with multiple organisations in Africa, Asia, Europe, North America and Oceania.
Will’s new book, Reputations at Stake, investigates how reputation requires careful management and explains the influence of reputations—from the...2023-06-2545 min
BELS Brief Chats podcastBELS Brief Chats #12 – Dr Fiona Marshall
Fiona Marshall discovered a love for science at school. She eschewed medicine for biochemistry at the University of Bath and then chose neuroscience for her PhD at Cambridge, while also accumulating industry experience. She lived through the transformation of Glaxo to GSK, shifted to biotech at Millennium where she worked with the likes of Allan Marchington (BELS Advisory Council member). After a mid-career break, she re-entered industry with Heptares and today is stationed in the US leading research at MSD/Merck & Co. A return to the UK will come in due course.
Meanwhile, Fiona carries positive feelings abou...2022-06-0228 min
BELS Brief Chats podcastBELS Brief Chats Episode #11 – Dr Gillian Leng, former Chief Executive of NICE
At the age of 10 she wanted to be a vet, at 17 a scientist, and at 21 she settled on medicine. Gillian Leng trained as a doctor at Leeds University, studied peripheral arterial disease in Edinburgh for several years, then worked as a consultant in public health in Bedfordshire. It’s no surprise that she considers joining NICE in 2001 to be her best career move, initially to set up the clinical guidelines program. Today some 400 guidelines are in place. During the COVID-19 pandemic, NICE rapidly created a suite of “living guidelines”. Now a shift toward such continuous updating is very much the direc...2022-02-1836 min
BELS Brief Chats podcastBELS Brief Chat podcast episode 10, Nigel Gaymond with Dr Calum Macrae, Chief of Cardiovascular Medicine, Brigham & Women's Hospital
Born into a medical family on the Isle of Skye, Dr Calum Macrae’s path to Edinburgh University and London to study medicine and become a leading cardiologist, geneticist and developmental biologist is not a great surprise. His drive to “follow the science” took him to Boston where he trained with seminal thought leaders in human genetics and gained world-class clinical training in internal medicine and cardiology. Calum’s interests—in genomics, disease modeling, developmental biology, drug discovery and systematic approaches to discovering new phenotypes—are overarched by a fascination with the role that disruptive innovation can have in refashioning the...2022-02-0246 min
BELS Brief Chats podcastBELS Brief Chats Episode #9 – Mike Grey
The conversation between Nigel Gaymond (in London amid rain of biblical proportions) and Mike Grey (in Utah amid smoke-filled air brought about by severe drought and forest fires) brought into sharp relief the weather extremes our planet is experiencing. Brought up in the West Midlands, Mike studied Chemistry at Nottingham University with support from local company Boots. His international journey through pharma and biotech ultimately led him to the fascinating world of company formation with Pappas Capital as a Venture Partner. He’s currently working on his 7th enterprise.
2021-09-2844 minBELS Brief Chats podcastBELS Brief Chats #8 – Dr Annalisa Jenkins
Dr Annalisa Jenkins grew up in the south of England in a naval family. Having discovered a passion medicine at an early age, she received offers from several medical schools and chose St. Bart’s – because it was in London (much to her parents’ chagrin). While in med school, she gained essential financial support for her medical training by joining the British Royal Navy during the Gulf Conflict, and spent nine years in the service, seeing wartime action as the only woman in a squadron of 700 men. Rising to the rank of Surgeon Lieutenant Commander and dodging silkworm missiles readied h...2021-07-281h 01
BELS Brief Chats podcastBELS Brief Chats #7 – Justin Gover
Justin Gover is the ex-CEO of GW Pharma—a great UK success story—known for treatments for epilepsy and the multiple sclerosis treatment product nabiximols which was the first natural cannabis plant derivative to gain market approval in any country. Justin shares his journey from studying politics at Bristol University to honing his skills at the global village that is INSEAD, the renowned graduate business school in Paris. He cut his teeth in life sciences by selling opiates in China. Back in the UK, he joined Ethical Holdings where he first met Geoffrey Guy and Brian Whittle, who envisioned crea...2021-07-2833 min
BELS Brief Chats podcastBELS Brief Chats podcast episode 6 Nigel Gaymond with John Young
John Young, Chief Business Officer at Pfizer, is that increasing rarity in today’s world, a one-company man who has never even interviewed elsewhere. John shares his journey from being raised in rural Dumfriesshire, Scotland, and schooled in Lockerbie, to studying biological sciences at Glasgow University, doing postgrad work at Strathclyde University, to deciding the lab was not going to be his domain and taking a job in sales with Pfizer, where he has grown and been challenged every since. After an initial 15 years of increasing seniority in sales roles, he expanded to marketing and then to more general sen...2021-06-0742 min
BELS Brief Chats podcastBELS Brief Chats podcast episode 5 - Nigel Gaymond with Mark Stevenson
Mark Stevenson, Executive Vice President and Chief Operating Officer of Thermo Fisher Scientific, grew up in the West Country in Gloucestershire (though he sheepishly admits to having lost his burr). He attended Reading University, attracted by their programme of industrial placements. Mark shares his journey from studying science and business to a training program at Perkin Elmer to developing his keen passion for new techniques around discoveries involving PCR, cell technologies and sequencing the human genome to his leadership role at Thermo Fisher and its many important contributions to fighting the COVID pandemic in the UK and globally.
...2021-06-0720 minBELS Brief Chats podcastBELS Brief Chats podcast episode 3 Nigel Gaymond with Dr Rupert Vessey
Dr Rupert Vessey—President of Early Development and Research at Bristol Myers Squibb—shares his journey from following the family tradition into medicine with Sir John Bell at Oxford University as his advisor while juggling a love and talent for rugby to then honing in on a career in research that led to his leadership role in R&D at Bristol Myers Squibb.
“The UK is in a great spot right now. I think they need access to experience and expertise, and I think BELS is able to tap into people who have a real passion for what th...2021-06-0442 min
BELS Brief Chats podcastBELS Brief Chats podcast episode 3 Nigel Gaymond with Dr David PyottDr David Pyott—portfolio board member, philanthropist, and former CEO & Chairman of Allergan—was destined for an international life which led to him live in 10 countries and work in 7. He shares his journey, from growing up in India and becoming fluent in Marathi, to attending Edinburgh University and London Business School, to becoming CEO of Sandoz Nutrition in Switzerland, to moving to California where he spent 17 years growing then-50-year-old Allergan as its third CEO. David and his board famously fought a “battle royale”, staving off a predatory acquirer before engineering a lucrative shareholder exit with Allergan's $66 billion sale to Actavis. ...2021-06-0330 min
BELS Brief Chats podcastBELS Brief Chat podcast episode 2, Nigel Gaymond with Dr Clive MeanwellDr Clive Meanwell—founder & CEO of Population Health Partners; founder & former CEO of The Medicines Company—shares his journey emanating from a family of teachers in Birmingham to earning his medical degree at University of Birmingham and playing first class rugby to a corporate career that led to him founding and leading The Medicines Company (acquired by Novartis in 2020) to launching a SPAC focused on transforming population health outcomes.
"Very few countries have as strategic a viewpoint on life sciences as the UK."2021-06-0334 minBELS Brief Chats podcastBELS Brief Chats #1 – Nigel GaymondNigel Gaymond, BELS Founder & Executive Chairman, provides a brief overview of BELS (British Educated Life Scientists) & the BELS Brief Chats podcast.2021-06-0300 min
FT Science with Clive CooksonBiotech and animal testingIn this week's podcast: We talk about the biotech industry with Nigel Gaymond, CEO of the UK BioIndustry Association. We also talk about the figures released by the Home Office today on animal testing. Presented by Clive Cookson with Diana Garnham, CEO of the Science Council.Produced by LJ Filotrani Hosted on Acast. See acast.com/privacy for more information.2010-07-2713 min